Member News

May 13, 2026

AbbVie in Canada Appoints Tanu Misra as Vice President and General Manager

MONTREAL, May 11, 2026 – AbbVie (NYSE: ABBV), a global research and development biopharmaceutical company, announced the appointment of Tanu Misra as Vice President and General Manager, to lead AbbVie in Canada.

“I am honored to step into this role at AbbVie Canada at a time when both science and healthcare policies are advancing at a rapid pace. Our purpose is clear: to translate innovation into meaningful health outcomes for patients, to partner with the healthcare community with integrity and imagination, and to build a culture where our people can realize their full potential. Together we have an opportunity – and an obligation – to make a lasting impact on lives across Canada.”

– said Tanu Misra, Vice President and General Manager, AbbVie in Canada.

Tanu joined AbbVie in 2012, working in gastroenterology in the United States and has since held leadership roles across multiple therapeutic areas. Most recently, she served as Vice President, Dermatology Psoriatic, U.S. Immunology, where she drove sustained growth through strong market insight, commercial strategy, and team leadership.


Prior to joining AbbVie, she spent more than ten years at Abbott Laboratories Inc. in Illinois, USA, where she developed deep expertise in commercial excellence and portfolio leadership.

Tanu is also actively engaged in community service. She serves on the Board of Bernie’s Book Bank, supported since 2014 by the AbbVie Foundation; she champions children’s literacy and helps empower future readers and leaders.

With more than 1,000 employees across Canada, AbbVie works to discover and develop medicines and solutions, impacting one million patients treated annually in Canada.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.

For more information about AbbVie in Canada, please visit us at www.abbvie.ca. Follow us on Instagram or find us on LinkedIn.

Media Inquiries:
Natacha Raphael
Head Of Corporate Affairs & Patient Engagement, Canada, AbbVie
natacha.raphael@abbvie.com

More News
& publications